AMANDA BALL: Open Payments
NPI 1891419073 · NEWBURY PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 36 payments from 11 companies in 2025. Trend: 2023 $119 · 2024 $285 · 2025 $758
Food & beverage: $756Education: $2
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 12 | $211 |
| Shionogi Inc | 8 | $188 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Aimmune Therapeutics, Inc. | 2 | $53 |
| ViiV Healthcare Company | 2 | $51 |
| Paratek Pharmaceuticals, Inc. | 2 | $51 |
| Melinta Therapeutics, LLC | 2 | $51 |
| Exact Sciences Corporation | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Insmed, Inc. | 1 | $18 |
Products named: Fetroja, ORGOVYX, VOWST, APRETUDE, NUZYRA, Rezzayo, Cologuard Collection Kit, PIFELTRO.
Industry payments across CA — which companies pay providers there.
